Increased circulating antiganglioside antibodies in primary and secondary progressive multiple sclerosis

Annals of Neurology

Volumn 44, Issue 6, 1998, Pages 980-983

  Sadatipour, B Tayyebeh ^a   Greer, Judith M ^a   Pender, Michael P ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE ANTIBODY; IMMUNOGLOBULIN G ANTIBODY;

ANTIBODY DETECTION; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; DEMYELINATING DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INFLAMMATORY DISEASE; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PRIORITY JOURNAL;

EID: 0031789948     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410440621     Document Type: Article

References (20)

1. Martin R, McFarland HF. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Crit Rev Clin Lab Sci 1995;32:121-182
2. Pender MP. Multiple sclerosis. In Pender MP, McCombe PA, eds. Autoimmune neurological disease. Cambridge, UK: Cambridge University Press, 1995:89-154
3. Greer JM, Csurhes PA, Cameron KD, et al. Increased immunoreactivity to two overlapping peptides of myelin proteolipid protein in multiple sclerosis. Brain 1997;120:1447-1460
4. Pender MP. Hypothesis: genetically determined failure of activation-induced apoptosis of autoreactive T cells as a cause of multiple sclerosis. Lancet 1998;351:978-981
5. Arnon R, Crisp E, Kelley R, et al. Anti-ganglioside antibodies in multiple sclerosis. J Neurol Sci 1980;46:179-186
6. Mullin BR, Montanaro AJ, Reid JD, Nishimura RN. Interaction of multiple sclerosis serum with liposomes containing ganglioside GM1. Ann Neurol 1980;7:587-590
7. Endo T, Scott DD, Stewart SS, et al. Antibodies to glycosphingolipids in patients with multiple sclerosis and SLE. J Immunol 1984;132:1793-1797
8. Feix JB, Khatri B, McQuillen MP, Koethe SM. Immune reactivity against membranes containing ganglioside GM1 in chronic-progressive multiple sclerosis: observation by spin-membrane immunoassay. Immunol Commun 1984;13:465-474
9. Kasai N, Pachner AR, Yu RK. Anti-glycolipid antibodies and their immune complexes in multiple sclerosis. J Neurol Sci 1986;75:33-42
10. Stevens A, Weller M, Wiethölter H. CSF and serum ganglioside antibody patterns in MS. Acta Neurol Scand 1992;86:485-489
11. Bech E, Jakobsen J, Ørntoft TF. ELISA-type titertray assay of IgM anti-GM1 autoantibodies. Clin Chem 1994;40:1331-1334
12. Acarin N, Rio J, Fernandez AL, et al. Different antiganglioside antibody pattern between relapsing-remitting and progressive multiple sclerosis. Acta Neurol Scand 1996;93:99-103
13. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:227-231
14. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 1996;46:907-911
15. Barnes D, Munro PM, Youl BD, et al. The longstanding MS lesion: a quantitative MRI and electron microscopic study. Brain 1991;114:1271-1280
16. Trapp BD, Peterson J, Ransohoff RM, et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998;338: 278-285
17. Thompson AJ, Polman CH, Miller DH, et al. Primary progressive multiple sclerosis. Brain 1997;120:1085-1096
18. Kusunoki S, Shimizu J, Chiba A, et al. Experimental sensory neuropathy induced by sensitization with ganglioside GD1b. Ann Neurol 1996;39:424-431
19. Kracun I, Rösner H, Cosovic C, Stavljenic A. Topographical atlas of the gangliosides of the adult human brain. J Neurochem 1984;43:979-989
20. Moody DB, Reinhold BB, Guy MR, et al. Structural requirements for glycolipid antigen recognition by CD1b-restricted T cells. Science 1997;278:283-286